# Northstar AI completion audit — 2026-11-12

## Snapshot and method

- Repository: `hamzaijaz9989/ai-stock-advisor`.
- Audited source: `main` at `5be851ea1bb976dd24d7ef9cfc94c34abff3ba29`.
- Working branch: `codex/northstar-completion-2026-11-12`.
- Production baseline: the latest recorded provider/deployment audit is in [Provider Health Audit](PROVIDER_HEALTH_AUDIT_2026-11-12.md). It verifies a finite window of FMP/Finnhub monitor data, not the Pages research endpoints or ongoing uptime.
- Percentages estimate completed behavior against the product's stated acceptance requirements. Source code and deterministic tests count as implementation evidence. Live provider evidence counts only for the provider and time window actually observed. An unmerged PR, design document, synthetic fixture, or passing unit suite does not count as production acceptance or investment-strategy validation.

## Overall completion: 66%

| Workstream | Completion | Evidence and remaining gap |
|---|---:|---|
| Equity scanner and shortlist | 85% | Scanner, cached shortlist and validation workflow exist. User-confirmed scanner milestone is complete; cache freshness and provider coverage still need operational monitoring. |
| Market data and provider integrations | 75% | FMP, Finnhub and Yahoo paths include source/timestamp checks and tested fallback behavior; production monitor has finite successful FMP/Finnhub observations. Pages secret/endpoint health is not freshly verified. |
| SEC, financial analysis and history | 65% | SEC facts/filings, point-in-time ingestion, valuation and research-history tooling exist. Research price history uses an unofficial source and is explicitly not decision-eligible; data coverage and availability timestamps are incomplete. |
| Research Council / Stock Brain | 65% | Nine logical roles, council orchestration, evidence IDs, deterministic risk gates and role tests exist in the repository. Full dashboard/collector acceptance work remains split across open PRs #108 and #116; production durable council traces are not evidenced. |
| Recommendations and strategy validation | 40% | WAIT/AVOID and risk calculations exist. BUY remains disabled; no complete point-in-time universe, frozen strategy, four-fold walk-forward, untouched holdout and independent approval package is evidenced. |
| Paper portfolio and lifecycle | 50% | Read-only Alpaca sync, paper controls, preflight, intents, reconciliation, fill handling and risk guards are implemented/tested. Production has no verified seven-day baseline or end-to-end order lifecycle; execution remains disabled and kill switch engaged. |
| Dashboard and user workflows | 75% | Research, history, positions, watchlist and Trading Lab surfaces exist with endpoint/UI tests. Some Council presentation and live acceptance changes remain unmerged. |
| Cloudflare operations and release | 70% | Pages/Worker workflows, D1 schema, scheduled monitoring and secret-safe configuration exist. Migration 0007 is proposed in open PR #139 and is not applied; current branch governance and exact-head release acceptance remain incomplete. |

This is a workstream estimate, not a claim that 66% of code is written or that the product is production-ready. Strategy validation and operational approval are hard gates regardless of this aggregate score.

## Agent completion estimates

| Agent | Completion | Implemented and tested | Remaining acceptance work |
|---|---:|---|---|
| Market Scanner | 80% | Evidence completeness, freshness, liquidity and coverage checks; scanner and shortlist tests. | Demonstrate stable cache freshness and role wiring in the accepted nine-role request path. |
| Technical Analyst | 80% | Deterministic trend, moving-average, RSI and volatility analysis from supplied history; synthetic tests. | Validate input coverage and corporate-action handling on licensed, point-in-time production history. |
| Fundamental Analyst | 80% | SEC/FMP observation coverage, period/unit checks and missing cross-check flags; tests. | Establish broader issuer coverage, fiscal-period alignment and availability semantics. |
| News Analyst | 65% | Timestamped discovery/source quality and freshness checks; tests. | Validate deduplication, issuer corroboration and provider entitlements in live use. |
| Sentiment Analyst | 10% | Contract rejects missing/invalid observations and reports unavailable. | No approved timestamped sentiment/positioning provider is connected. |
| Bull Researcher | 70% | Specialist role and evidence-referenced output contract are implemented. | Verify the complete collector-to-dashboard path and semantic support through reviewed live runs. |
| Bear Researcher | 70% | Specialist role and evidence-referenced downside analysis contract are implemented. | Verify the complete collector-to-dashboard path and semantic support through reviewed live runs. |
| Portfolio Analyst | 60% | Portfolio context and synthesis role exist; missing context is gated in tests. | Production-quality portfolio history/context and durable end-to-end collector acceptance remain incomplete. |
| Risk Committee | 85% | Deterministic fail-closed committee and paper risk guards are tested. | Keep independent validation and human-review gates closed until strategy evidence is approved. |

The role percentages measure software behavior, not the quality of generated investment conclusions or predictive performance.

## Audit findings and work completed in this branch

1. Main already contains a broad research, market-data and paper-only implementation; replacing it would be counterproductive. User-confirmed scanner work was treated as complete.
2. Open PRs #108 and #116 contain additional Stock Brain integration and acceptance work; they are not part of the audited `main` snapshot. PR #139 contains a proposed explicit FMP-budget migration and shortlist rotation; migration 0007 is not applied.
3. The quote endpoint accepted non-positive Yahoo/Nasdaq prices and could return a quote without a normalized observation timestamp. This conflicts with the endpoint's fail-closed data policy and the timestamp requirements used by other providers.
4. This branch now rejects non-positive/non-finite prices and missing/invalid timestamps from Yahoo and Nasdaq, allowing the existing configured provider fallbacks to continue. If no provider returns a usable observation, the endpoint returns 503. Added three regression tests for rejection, fallback and valid Yahoo behavior.

## Verification

- JavaScript tests on the audited `main` snapshot: 243 assertions passed across 36 files. After this change, 246 assertions passed across 37 files, run one file per Node process because this execution environment denies Node's test-runner child-process spawning.
- New quote endpoint tests after the change: 3 passed; `node --check` and `git diff --check` passed.
- Python tests and Ruff could not run locally because Python and Ruff are not installed in the task environment. Exact-head GitHub Actions Tests workflow run `43181944912` on commit `e29dd7bc3778bf9c47abac131fabf8cc68f94d5e` passed, including Python tests, JavaScript tests, script syntax checks and Ruff.
- After the audit refresh and line-ending normalization, GitHub Actions Tests run `43182201309` passed on exact head `ab0434ee0427e78b1404b06e4f961879edef2446`, including Python tests, JavaScript tests, syntax checks and Ruff.
- No production setting, D1 data, secret, paper control, or order was changed. No deployment was performed.
- Public web probes for the homepage, `/api/quote` and `/api/fmp-health` were inaccessible from the available browser tool, so current production Pages behavior was not independently verified in this session.

## Remaining priorities

1. Review and consolidate the non-draft Stock Brain PR #108 with the later integration proposal #116; resolve divergence and verify all nine outcomes, resource gaps, telemetry, durable traces and dashboard presentation on one exact head.
2. Run complete exact-head CI, including Python tests and Ruff, and verify the matching Preview deployment and endpoints.
3. Apply and verify migration 0007 only through the reviewed migration process; do not remove the runtime guard until schema parity is confirmed.
4. Establish licensed, point-in-time historical inputs and complete frozen-strategy walk-forward/holdout validation with independent review. Keep BUY disabled until approval.
5. Complete paper lifecycle recovery, seven-day equity history and failure-injection acceptance while preserving execution disabled and the kill switch engaged.
6. Reconcile current production Pages/Worker evidence, including Pages provider health and subsequent scheduled monitor continuity, before any release decision.
